Ace the Case: An 84-Year-Old Man With Neovascular Age-Related Macular Degeneration Receiving Bilateral Every 8-Week Anti-Vascular Endothelial Growth Factor Injections is organized by Healio, Vindico Medical Education.
Release Date: June 30, 2023
Expiration Date: June 29, 2024
Activity Description:
In this clinical case review, Dr. Emmanuel Chang explores options to extend treatment intervals in a patient with stable nAMD who is receiving anti-vascular endothelial grown factor (VEGF) therapy every 8 weeks.
Learning Objectives:
Upon successful completion of this activity, participants should be better able to:
• Utilize assessment techniques and tools that aid in determining patients who would benefit from injectables that offer extended intervals between treatments in nAMD.
• Select treatment protocols that improve adherence to therapy in patients with nAMD.